Abstract
Prior studies suggest that endomyocardial implantation of autologous bone marrow (BM) mononuclear cell therapy improves symptoms and left ventricular (LV) function in patients with refractory angina; however, the therapeutic efficacy in patients with ischemic cardiomyopathy is unclear. In a randomized, double-blind, placebo-controlled trial, 28 patients with advanced ischemic cardiomyopathy [New York Heart Association III-IV, LV ejection fraction (LVEF) <40 %] were assigned in 2:1 ratio to receive endomyocardial injection of BM cells (100 million, n = 19) or placebo (n = 9), guided by electroanatomical mapping. After 6 months, there was no significant difference between the two groups in LV ejection fraction (LVEF) and LV end-systolic volume (LVESV), LV infarct volume, and LV peri-infarct ischemic volume as determined by cardiac magnetic resonance imaging or exercise capacity. In conclusion, endomyocardial implantation of autologous BM mononuclear cells did not improve LV function or remodeling in patients with advanced ischemic cardiomyopathy.
Similar content being viewed by others
References
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., Franco, S., Fullerton, H. J., Gillespie, C., Hailpern, S. M., Heit, J. A., Howard, V. J., Huffman, M. D., Kissela, B. M., Kittner, S. J., Lackland, D. T., Lichtman, J. H., Lisabeth, L. D., Magid, D., Marcus, G. M., Marelli, A., Matchar, D. B., McGuire, D. K., Mohler, E. R., Moy, C. S., Mussolino, M. E., Nichol, G., Paynter, N. P., Schreiner, P. J., Sorlie, P. D., Stein, J., Turan, T. N., Virani, S. S., Wong, N. D., Woo, D., & Turner, M. B. (2013). American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation, 127, 143–152.
Blecker, S., Paul, M., Taksler, G., Ogedegbe, G., & Katz, S. (2013). Heart failure associated hospitalizations in the United States. Journal of the American College of Cardiology, 61, 1259–1267.
McMurray, J. J. (2010). Systolic heart failure. New England Journal of Medicine, 362, 228–238.
Siu, C. W., & Tse, H. F. (2012). Cardiac regeneration: messages from CADUCEUS. Lancet, 379, 870–871.
Deutsch, M. A., Sturzu, A., & Wu, S. M. (2013). At a crossroad: cell therapy for cardiac repair. Circulation Research, 112, 884–890.
Perin, E. C., Dohmann, H. F., Borojevic, R., Silva, S. A., Sousa, A. L., Mesquita, C. T., Rossi, M. I., Carvalho, A. C., Dutra, H. S., Dohmann, H. J., Silva, G. V., Belém, L., Vivacqua, R., Rangel, F. O., Esporcatte, R., Geng, Y. J., Vaughn, W. K., Assad, J. A., Mesquita, E. T., & Willerson, J. T. (2003). Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation, 107, 2294–2302.
Perin, E. C., Dohmann, H. F., Borojevic, R., Silva, S. A., Sousa, A. L., Silva, G. V., Mesquita, C. T., Belém, L., Vaughn, W. K., Rangel, F. O., Assad, J. A., Carvalho, A. C., Branco, R. V., Rossi, M. I., Dohmann, H. J., & Willerson, J. T. (2004). Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation, 110(11 Suppl 1), II213–II218.
Fuchs, S., Kornowski, R., Weisz, G., Satler, L. F., Smits, P. C., Okubagzi, P., Baffour, R., Aggarwal, A., Weissman, N. J., Cerqueira, M., Waksman, R., Serrruys, P., Battler, A., Moses, J. W., Leon, M. B., & Epstein, S. E. (2006). Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. American Journal of Cardiology, 97, 823–829.
Losordo, D. W., Schatz, R. A., White, C. J., Udelson, J. E., Veereshwarayya, V., Durgin, M., Poh, K. K., Weinstein, R., Kearney, M., Chaudhry, M., Burg, A., Eaton, L., Heyd, L., Thorne, T., Shturman, L., Hoffmeister, P., Story, K., Zak, V., Dowling, D., Traverse, J. H., Olson, R. E., Flanagan, J., Sodano, D., Murayama, T., Kawamoto, A., Kusano, K. F., Wollins, J., Welt, F., Shah, P., Soukas, P., Asahara, T., & Henry, T. D. (2007). Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation, 115, 3165–3172.
Tse, H. F., Thambar, S., Kwong, Y. L., Rowlings, P., Bellamy, G., McCrohon, J., Thomas, P., Bastian, B., Chan, J. K., Lo, G., Ho, C. L., Chan, W. S., Kwong, R. Y., Parker, A., Hauser, T. H., Chan, J., Fong, D. Y., & Lau, C. P. (2007). Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). European Heart Journal, 28, 2998–3005.
van Ramshorst, J., Bax, J. J., Beeres, S. L., Dibbets-Schneider, P., Roes, S. D., Stokkel, M. P., de Roos, A., Fibbe, W. E., Zwaginga, J. J., Boersma, E., Schalij, M. J., & Atsma, D. E. (2009). Intramyocardial bone marrow cell injection for chronic myocardial ischemia. JAMA, 301, 1997–2004.
Perin, E. C., Silva, G. V., Henry, T. D., Cabreira-Hansen, M. G., Moore, W. H., Coulter, S. A., Herlihy, J. P., Fernandes, M. R., Cheong, B. Y., Flamm, S. D., Traverse, J. H., Zheng, Y., Smith, D., Shaw, S., Westbrook, L., Olson, R., Patel, D., Gahremanpour, A., Canales, J., Vaughn, W. K., & Willerson, J. T. (2011). A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). American Heart Journal, 161, 1078–1087.
Losordo, D. W., Henry, T. D., Davidson, C., Sup Lee, J., Costa, M. A., Bass, T., Mendelsohn, F., Fortuin, F. D., Pepine, C. J., Traverse, J. H., Amrani, D., Ewenstein, B. M., Riedel, N., Story, K., Barker, K., Povsic, T. J., Harrington, R. A., & Schatz, R. A. (2011). ACT34-CMI Investigators. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circulation Research, 109, 428–436.
Perin, E. C., Willerson, J. T., Pepine, C. J., Henry, T. D., Ellis, S. G., Zhao, D. X., Silva, G. V., Lai, D., Thomas, J. D., Kronenberg, M. W., Martin, A. D., Anderson, R. D., Traverse, J. H., Penn, M. S., Anwaruddin, S., Hatzopoulos, A. K., Gee, A. P., Taylor, D. A., Cogle, C. R., Smith, D., Westbrook, L., Chen, J., Handberg, E., Olson, R. E., Geither, C., Bowman, S., Francescon, J., Baraniuk, S., Piller, L. B., Simpson, L. M., Loghin, C., Aguilar, D., Richman, S., Zierold, C., Bettencourt, J., Sayre, S. L., Vojvodic, R. W., Skarlatos, S. I., Gordon, D. J., Ebert, R. F., Kwak, M., Moyé, L. A., Simari, R. D., & Cardiovascular Cell Therapy Research Network (CCTRN). (2012). Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA, 307, 1717–1726.
Grothues, F., Smith, G. C., Moon, J. C., Bellenger, N. G., Collins, P., Klein, H. U., & Pennell, D. J. (2002). Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. American Journal of Cardiology, 90, 29–34.
Kim, R. J., Wu, E., Rafael, A., Chen, E. L., Parker, M. A., Simonetti, O., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000). The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New England Journal of Medicine, 343, 1445–1453.
Chan, C. W., Kwong, Y. L., Kwong, R. Y., Lau, C. P., & Tse, H. F. (2010). Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease. Journal of Cardiovascular Magnetic Resonance, 12, 6.
Santoso, T., Siu, C. W., Irawan, C., Chan, C. S., Alwi, I., Yiu, K. H., Azis, A., Kwong, Y. L., Tse, H. F. (2013). A randomized placebo controlled trial of endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure (END-HF). European Heart Journal, 34(suppl 1). doi:10.1093/eurheartj/eht309.3554.
Tse, H. F., Wong, K. K., Siu, C. W., Zhang, X. H., Ho, W. Y., & Lau, C. P. (2009). Upgrading pacemaker patients with right ventricular apical pacing to right ventricular septal pacing improves left ventricular performance and functional capacity. Journal of Cardiovascular Electrophysiology, 20, 901–905.
Laflamme, M. A., & Murry, C. E. (2011). Heart regeneration. Nature, 473, 326–335.
Hofmann, M., Wollert, K. C., Meyer, G. P., Menke, A., Arseniev, L., Hertenstein, B., Ganser, A., Knapp, W. H., & Drexler, H. (2005). Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation, 111, 2198–2202.
Liao, R., Pfister, O., Jain, M., & Mouquet, F. (2007). The bone marrow—cardiac axis of myocardial regeneration. Progress in Cardiovascular Diseases, 50, 18–30.
Yiu, K. H., & Tse, H. F. (2014). Specific role of impaired glucose metabolism and diabetes mellitus in endothelial progenitor cell characteristics and function. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1136–1143.
Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H., Zeiher, A. M., & Dimmeler, S. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Research, 89, E1–E7.
Lai, W. H., Ho, J. C., Chan, Y. C., Ng, J. H., Au, K. W., Wong, L. Y., Siu, C. W., & Tse, H. F. (2013). Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells. PLoS One, 8, e57876.
Poole, J. C., & Quyyumi, A. A. (2013). Progenitor cell therapy to treat acute myocardial infarction: the promise of high-dose autologous CD34(+) bone marrow mononuclear cells. Stem Cells International.
Williams, A. R., & Hare, J. M. (2011). Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circulation Research, 109, 923–940.
Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., Tracy, M., Ghersin, E., Johnston, P. V., Brinker, J. A., Breton, E., Davis-Sproul, J., Schulman, I. H., Byrnes, J., Mendizabal, A. M., Lowery, M. H., Rouy, D., Altman, P., Wong Po Foo, C., Ruiz, P., Amador, A., Da Silva, J., McNiece, I. K., & Heldman, A. W. (2012). Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA, 308, 2369–2379.
Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., Banovic, M., Beleslin, B., Vrolix, M., Legrand, V., Vrints, C., Vanoverschelde, J. L., Crespo-Diaz, R., Homsy, C., Tendera, M., Waldman, S., Wijns, W., & Terzic, A. (2013). Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. Journal of the American College of Cardiology, 61, 2329–2338.
Williams, A. R., Hatzistergos, K. E., Addicott, B., McCall, F., Carvalho, D., Suncion, V., Morales, A. R., Da Silva, J., Sussman, M. A., Heldman, A. W., & Hare, J. M. (2013). Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation, 127, 213–223.
Acknowledgments
This study was supported by the S.K. Yee Medical Foundation Grant (208207); and Research Grant Council of Hong Kong: General Research Fund (no. HKU 780110M); the Collaborative Research Fund (HKU 8/CRF/09); and Theme Based Research Scheme (T12-705/11).
Disclosures
This study was presented at the European Society of Cardiology Congress 2013 and as a published abstract: Eur Heart J. 2013; 34 (suppl 1): doi: 10.1093/eurheartj/eht309.3554.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Lorrie Kirshenbaum oversaw the review of this article
Rights and permissions
About this article
Cite this article
Santoso, T., Siu, CW., Irawan, C. et al. Endomyocardial Implantation of Autologous Bone Marrow Mononuclear Cells in Advanced Ischemic Heart Failure: a Randomized Placebo-Controlled Trial (END-HF). J. of Cardiovasc. Trans. Res. 7, 545–552 (2014). https://doi.org/10.1007/s12265-014-9580-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-014-9580-6